Literature DB >> 19228646

Histopathologic analysis of sixteen autopsy cases of chronic hypersensitivity pneumonitis and comparison with idiopathic pulmonary fibrosis/usual interstitial pneumonia.

Takumi Akashi1, Tamiko Takemura, Noboru Ando, Yoshinobu Eishi, Masanobu Kitagawa, Touichirou Takizawa, Morio Koike, Yoshio Ohtani, Yasunari Miyazaki, Naohiko Inase, Yasuyuki Yoshizawa.   

Abstract

Hypersensitivity pneumonitis (HP) is an interstitial lung disease caused by the inhalation of organic substances and certain inorganic chemicals. The histopathologic features of chronic HP (CHP) have not been studied extensively. We examined the pathologic characteristics of 16 autopsy cases of clinically confirmed CHP and compared them with 11 cases of idiopathic pulmonary fibrosis/usual interstitial pneumonia (IPF/UIP). To clarify the exact intralobular location of the fibrotic lesions, we conducted 3-dimensional reconstruction of fibrosis of CHP and IPF/UIP. Granuloma was not detected in any CHP case. Similar to IPF/UIP, honeycombing lesions were found dominantly in the lower lobes in most CHP cases; upper lobe dominance and asymmetrical distribution of honeycomb lesions were more frequent in CHP than in IPF/UIP. In all lungs affected by CHP, centrilobular fibrosis was outstanding, often connecting to the perilobular areas in the appearance of "bridging fibrosis," which was clearly demonstrated by 3-dimensional imaging. Centrilobular and bridging fibrosis were significantly more conspicuous in CHP than IPF/UIP; however, considerable overlap was found. It is important to thoroughly explore the possibility of antigen exposure in cases of lungs with UIP with centrilobular fibrosis to discriminate CHP from IPF/UIP.

Entities:  

Mesh:

Year:  2009        PMID: 19228646     DOI: 10.1309/AJCPNWX4SLZRP9SW

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  15 in total

1.  Chronic interstitial pneumonia in young patients undergoing lung transplantation or autopsy: clinico-radiologic-pathologic observations from a single institution.

Authors:  Mayu Uka; Toshihiro Iguchi; Katsuya Kato; Hidehiro Hayashi; Ichiro Yamadori; Toshiharu Mitsuhashi; Takahiro Oto; Shuhei Sato; Susumu Kanazawa
Journal:  Jpn J Radiol       Date:  2016-05-11       Impact factor: 2.374

2.  A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease. An International Working Group Perspective.

Authors:  Christopher J Ryerson; Tamera J Corte; Joyce S Lee; Luca Richeldi; Simon L F Walsh; Jeffrey L Myers; Jürgen Behr; Vincent Cottin; Sonye K Danoff; Kevin R Flaherty; David J Lederer; David A Lynch; Fernando J Martinez; Ganesh Raghu; William D Travis; Zarir Udwadia; Athol U Wells; Harold R Collard
Journal:  Am J Respir Crit Care Med       Date:  2017-11-15       Impact factor: 21.405

Review 3.  Diagnosis and Treatment of Fibrotic Hypersensitivity Pneumonia. Where We Stand and Where We Need to Go.

Authors:  Margaret L Salisbury; Jeffrey L Myers; Elizabeth A Belloli; Ella A Kazerooni; Fernando J Martinez; Kevin R Flaherty
Journal:  Am J Respir Crit Care Med       Date:  2017-09-15       Impact factor: 21.405

Review 4.  Hypersensitivity pneumonitis.

Authors:  Ulrich Costabel; Yasunari Miyazaki; Annie Pardo; Dirk Koschel; Francesco Bonella; Paolo Spagnolo; Josune Guzman; Christopher J Ryerson; Moises Selman
Journal:  Nat Rev Dis Primers       Date:  2020-08-06       Impact factor: 52.329

5.  An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.

Authors:  William D Travis; Ulrich Costabel; David M Hansell; Talmadge E King; David A Lynch; Andrew G Nicholson; Christopher J Ryerson; Jay H Ryu; Moisés Selman; Athol U Wells; Jurgen Behr; Demosthenes Bouros; Kevin K Brown; Thomas V Colby; Harold R Collard; Carlos Robalo Cordeiro; Vincent Cottin; Bruno Crestani; Marjolein Drent; Rosalind F Dudden; Jim Egan; Kevin Flaherty; Cory Hogaboam; Yoshikazu Inoue; Takeshi Johkoh; Dong Soon Kim; Masanori Kitaichi; James Loyd; Fernando J Martinez; Jeffrey Myers; Shandra Protzko; Ganesh Raghu; Luca Richeldi; Nicola Sverzellati; Jeffrey Swigris; Dominique Valeyre
Journal:  Am J Respir Crit Care Med       Date:  2013-09-15       Impact factor: 21.405

6.  Role of Krebs von den Lungen-6 (KL-6) in Assessing Hypersensitivity Pneumonitis.

Authors:  Amira Ismail Mostafa; Ayman Elsayed Salem; Heba Allah Moussa Ahmed; Aml Ibrahim Bayoumi; Radwa M Abdel Halim; Rasha M Abdel Samie
Journal:  Tuberc Respir Dis (Seoul)       Date:  2021-04-06

7.  Immunoglobulin free light chains are increased in hypersensitivity pneumonitis and idiopathic pulmonary fibrosis.

Authors:  Tom Groot Kormelink; Annie Pardo; Karen Knipping; Ivette Buendía-Roldán; Carolina García-de-Alba; Bart R Blokhuis; Moises Selman; Frank A Redegeld
Journal:  PLoS One       Date:  2011-09-28       Impact factor: 3.240

8.  Case-based discussion: Lymphocytic interstitial pneumonia a rare presentation in an immunocompetent adult male.

Authors:  Ajay Chitnis; Pradeep Kumar Vyas; Priyanka Chaudhary; Gaurav Ghatavat
Journal:  Lung India       Date:  2015 Sep-Oct

9.  Reliability of histopathologic diagnosis of fibrotic interstitial lung disease: an international collaborative standardization project.

Authors:  Robert Camp; Maxwell L Smith; Brandon T Larsen; Anja C Roden; Carol Farver; Andre L Moreira; Richard Attanoos; Raghavendra Pillappa; Irene Sansano; Alexandre Todorovic Fabro; Robert J Homer
Journal:  BMC Pulm Med       Date:  2021-06-01       Impact factor: 3.317

10.  Management of hypersensivity pneumonitis.

Authors:  Ioana O Agache; Liliana Rogozea
Journal:  Clin Transl Allergy       Date:  2013-02-04       Impact factor: 5.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.